Mobile

A Phase III, Randomized, Observer-Blind, Placebo-Controlled, Multicenter Study to Assess Clinical Efficacy of a Cell-Derived Subunit Influenza Vaccine and an Egg-Derived Subunit Influenza Vaccine in t...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-002871-15

A Phase III, Randomized, Observer-Blind, Placebo-Controlled, Multicenter Study to Assess Clinical Efficacy of a Cell-Derived Subunit Influenza Vaccine and an Egg-Derived Subunit Influenza Vaccine in the 2007-2008 Influenza Season in Healthy Adult Subjects

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

•To demonstrate protection of a cell-derived influenza vaccine compared to placebo against illness caused by virus-confirmed community-acquired influenza wild type strains antigenically similar to those contained in the vaccines. •To demonstrate protection of an egg-derived influenza vaccine compared to placebo against illness2 caused by virus-confirmed community-acquired influenza wild type strains antigenically similar to those contained in the vaccines.

Critère d'inclusion

  • Influenza Disease

Liens